Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) flaunted slowness of -30.22% at $0.41, before settling in for the price of $0.59 at the close. Taking a more long-term approach, QNRX posted a 52-week range of $0.43-$6.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was -194.79%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 78.42%. This publicly-traded company’s shares outstanding now amounts to $5.05 million, simultaneously with a float of $1.12 million. The organization now has a market capitalization sitting at $2.08 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6330, while the 200-day Moving Average is $0.6511.
Quoin Pharmaceuticals Ltd ADR (QNRX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Quoin Pharmaceuticals Ltd ADR industry. According to the most recent insider trade that took place on Dec 23 ’24, this organization’s Chief Operating Officer bought 555,556 shares at the rate of 0.45, making the entire transaction reach 250,000 in total value, affecting insider ownership by 602,648. Preceding that transaction, on Dec 23 ’24, Company’s Chief Executive Officer bought 555,556 for 0.45, making the whole transaction’s value amount to 250,000. This particular insider is now the holder of 602,808 in total.
Quoin Pharmaceuticals Ltd ADR (QNRX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
Quoin Pharmaceuticals Ltd ADR’s EPS increase for this current 12-month fiscal period is 78.42% and is forecasted to reach -1.48 in the upcoming year.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Trading Performance Indicators
Let’s observe the current performance indicators for Quoin Pharmaceuticals Ltd ADR (QNRX). It’s Quick Ratio in the last reported quarter now stands at 3.02. The Stock has managed to achieve an average true range (ATR) of 0.09.
In the same vein, QNRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.08, a figure that is expected to reach -0.46 in the next quarter, and analysts are predicting that it will be -1.48 at the market close of one year from today.
Technical Analysis of Quoin Pharmaceuticals Ltd ADR (QNRX)
Now, what If we examine the latest scores posted by [Quoin Pharmaceuticals Ltd ADR, QNRX]. During the last 5-days, its volume was better the volume of 4.73 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 28.12% While, its Average True Range was 0.0923.
Raw Stochastic average of Quoin Pharmaceuticals Ltd ADR (QNRX) in the period of the previous 100 days is set at 0.97%, which indicates a major fall in contrast to 2.78% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 156.39% that was lower than 157.74% volatility it exhibited in the past 100-days period.
